SEC Form 4 · accession 0001127602-18-016151
Encompass Health Corp · EHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara Ann Jacobsmeyer
Officer — President, Inpatient Hospitals
Period of report
May 2, 2018
Accepted (ET)
May 3, 2018 · 12:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000785161
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Encompass Health Common Stock | May 2, 2018 | M | 3,897 | $42.22 | A | 37,964 | D | |
| Encompass Health Common StockF1 | May 2, 2018 | S | 3,897 | $62.51 | D | 34,067 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F2 | $42.22 | May 2, 2018 | M | 3,897 | D | Feb 24, 2018 | Feb 24, 2027 | Encompass Health Common Stock | 3,897 | 7,792 | D |
Explanation of responses
- F1This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $62.490 to $62.515, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
- F2The option was exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing February 24, 2018.